These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 19054549)

  • 1. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science.
    Wentzensen N; Sherman ME; Schiffman M; Wang SS
    Gynecol Oncol; 2009 Feb; 112(2):293-9. PubMed ID: 19054549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel epigenetic changes in CDKN2A are associated with progression of cervical intraepithelial neoplasia.
    Wijetunga NA; Belbin TJ; Burk RD; Whitney K; Abadi M; Greally JM; Einstein MH; Schlecht NF
    Gynecol Oncol; 2016 Sep; 142(3):566-73. PubMed ID: 27401842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women.
    Vasiljević N; Scibior-Bentkowska D; Brentnall AR; Cuzick J; Lorincz AT
    Gynecol Oncol; 2014 Mar; 132(3):709-14. PubMed ID: 24508839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
    Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
    Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions.
    De Strooper LM; Meijer CJ; Berkhof J; Hesselink AT; Snijders PJ; Steenbergen RD; Heideman DA
    Cancer Prev Res (Phila); 2014 Dec; 7(12):1251-7. PubMed ID: 25281488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.
    De Strooper LMA; Berkhof J; Steenbergen RDM; Lissenberg-Witte BI; Snijders PJF; Meijer CJLM; Heideman DAM
    Int J Cancer; 2018 Sep; 143(6):1541-1548. PubMed ID: 29663363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
    Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC
    Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential gene promoter methylation during HPV-induced cervical carcinogenesis.
    Henken FE; Wilting SM; Overmeer RM; van Rietschoten JG; Nygren AO; Errami A; Schouten JP; Meijer CJ; Snijders PJ; Steenbergen RD
    Br J Cancer; 2007 Nov; 97(10):1457-64. PubMed ID: 17971771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation analysis in liquid-based cytology for cervical cancer screening.
    Apostolidou S; Hadwin R; Burnell M; Jones A; Baff D; Pyndiah N; Mould T; Jacobs IJ; Beddows S; Kocjan G; Widschwendter M
    Int J Cancer; 2009 Dec; 125(12):2995-3002. PubMed ID: 19609949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
    Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
    Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel DNA methylation markers in cervical cancer.
    Lai HC; Lin YW; Huang TH; Yan P; Huang RL; Wang HC; Liu J; Chan MW; Chu TY; Sun CA; Chang CC; Yu MH
    Int J Cancer; 2008 Jul; 123(1):161-7. PubMed ID: 18398837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease.
    Babion I; De Strooper LMA; Luttmer R; Bleeker MCG; Meijer CJLM; Heideman DAM; Wilting SM; Steenbergen RDM
    Epigenetics; 2019 Jun; 14(6):558-567. PubMed ID: 30955437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of candidate methylation markers to detect cervical neoplasia.
    Shivapurkar N; Sherman ME; Stastny V; Echebiri C; Rader JS; Nayar R; Bonfiglio TA; Gazdar AF; Wang SS
    Gynecol Oncol; 2007 Dec; 107(3):549-53. PubMed ID: 17894941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative DNA methylation analysis of candidate genes in cervical cancer.
    Siegel EM; Riggs BM; Delmas AL; Koch A; Hakam A; Brown KD
    PLoS One; 2015; 10(3):e0122495. PubMed ID: 25826459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape.
    Snellenberg S; De Strooper LM; Hesselink AT; Meijer CJ; Snijders PJ; Heideman DA; Steenbergen RD
    BMC Cancer; 2012 Nov; 12():551. PubMed ID: 23176198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study.
    Bonde J; Floore A; Ejegod D; Vink FJ; Hesselink A; van de Ven PM; Valenčak AO; Pedersen H; Doorn S; Quint WG; Petry KU; Poljak M; Stanczuk G; Cuschieri K; de Sanjosé S; Bleeker M; Berkhof J; Meijer CJLM; Heideman DAM
    Int J Cancer; 2021 Jan; 148(2):396-405. PubMed ID: 32997803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.
    Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
    Gynecol Oncol; 2010 Jan; 116(1):99-104. PubMed ID: 19836067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification of HPV 16 DNA methylation combined with E6 oncoprotein in cervical cancer screening: a 10-year prospective cohort study.
    Dong L; Zhang L; Hu SY; Feng RM; Zhao XL; Zhang Q; Pan QJ; Zhang X; Qiao YL; Zhao FH
    Clin Epigenetics; 2020 May; 12(1):62. PubMed ID: 32381054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients.
    Eijsink JJ; Lendvai Á; Deregowski V; Klip HG; Verpooten G; Dehaspe L; de Bock GH; Hollema H; van Criekinge W; Schuuring E; van der Zee AG; Wisman GB
    Int J Cancer; 2012 Apr; 130(8):1861-9. PubMed ID: 21796628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.
    Clarke MA; Luhn P; Gage JC; Bodelon C; Dunn ST; Walker J; Zuna R; Hewitt S; Killian JK; Yan L; Miller A; Schiffman M; Wentzensen N
    Int J Cancer; 2017 Aug; 141(4):701-710. PubMed ID: 28500655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.